About Consolidated Craft Brands
Consolidated Craft Brands develops edible and infused wellness products for the cannabis industry.On January 12th, 2021, Consolidated Craft Brands was acquired by Rapid Dose Therapeutics.93M.
Missing: Consolidated Craft Brands's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Consolidated Craft Brands's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Consolidated Craft Brands
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Consolidated Craft Brands is included in 1 Expert Collection, including Cannabis.
These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.
Latest Consolidated Craft Brands News
Mar 20, 2021
03/19/2021 | 05:45pm EDT Message : *Required fields BURLINGTON, Ontario, March 19, 2021 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) , is a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions. The flagship product ‘QuickStrip™’ is a thin, orally dissolvable film infused with an active ingredient (nutraceuticals, cannabis or pharmaceuticals) that is delivered quickly into the bloodstream bypassing first-pass metabolism resulting in rapid onset of the active ingredient. The Company is announcing today that, further to its press release of March 8, 2021, it has closed the purchase and subsequent amalgamation of 2544737 Ontario Limited, operating as Consolidated Craft Brands (“CCB”), in a share transaction totalling $5,000,000 CDN. (Five million dollars Canadian). The transaction is an acquisition by RDT of CCB with CCB being amalgamated into a newly created subsidiary of RDT. 20,000,000 Units consisting of 1 common share and 1 common share purchase warrant have been issued subject to an eleven month escrow arrangement. Each common share has a deemed value of $0.25 per share while each warrant entitles the holder to acquire one common share of the Company at a price of $0.375 per common share for a two year period from the issuance date. In exchange, CCB becomes a wholly owned subsidiary of RDT. CCB brings CPG and Pharma manufacturing expertise, a Health Canada R&D License with developed proprietary formulations, branded products, several patent pending technologies for rapid onset beverage enhancements and a consortium of strategic alliances including First Nation majority shareholders. The balance sheet of CCB includes $3,000,000 in cash and cash equivalents including a repayable advance of $600,000 to RDT as an advance to closing of the transaction, equipment, inventory, patent pending technologies and the R&D License. In addition, liabilities in CCB are less than $50,000. The cash is now available to RDT to fund the ramp up of production to meet demand as it enters the Commercialization and Rapid Growth Phase in its development. About RDT Rapid Dose Therapeutics Corp. is a publicly-traded Canadian life sciences company providing innovative, proprietary drug delivery technologies designed to improve outcomes and quality of lives. RDT offers Quick, Convenient, Precise and Discreet™ choices to consumers. RDT is focused and committed to clinical research and product development for the healthcare manufacturing industry — including nutraceutical, pharmaceutical and cannabis industries. Within the cannabis sector, RDT also provides a turn-key Managed Strip Service Program enabling RDT’s QuickStrip™ proprietary cannabis delivery technology to be licensed to select operators in identified markets. RDT’s service-based annuity contracts drive recurring revenue and facilitate rapid expansion into emerging markets across multiple consumer segments. RDT is committed to continually create innovative solutions for humans, animals, and plants. For more information, visit: www.rapiddose.ca For inquiries please contact:
Consolidated Craft Brands Frequently Asked Questions (FAQ)
Where is Consolidated Craft Brands's headquarters?
Consolidated Craft Brands's headquarters is located at 2-31 Adams Blvd., Brantford.
What is Consolidated Craft Brands's latest funding round?
Consolidated Craft Brands's latest funding round is Acquired.
Who are the investors of Consolidated Craft Brands?
Investors of Consolidated Craft Brands include Rapid Dose Therapeutics.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.